Advice
NICE has developed a medtech innovation briefing (MIB) on RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease.
This MIB should be read alongside NICE diagnostics guidance on therapeutic monitoring of TNF-alpha inhibitors in Crohn’s disease.